Supernus Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 207.7M | 211.6M | 192.1M | 165.5M | 149.8M | 174.2M | 175.7M | 168.3M |
| Cost of Goods Sold | 23.4M | 23.0M | 19.0M | 16.8M | 15.8M | 26.1M | 17.6M | 17.9M |
| Gross Profit | 184.3M | 188.6M | 173.1M | 148.6M | 134.1M | 148.1M | 158.1M | 150.4M |
| R&D Expenses | 39.4M | 27.8M | 29.4M | 22.1M | 26.9M | 28.6M | 29.0M | 26.2M |
| Operating Expenses | 192.6M | 174.7M | 233.4M | 136.5M | 144.3M | 126.7M | 117.3M | 127.8M |
| Operating Income | -7.4M | 13.8M | -60.2M | 12.1M | -10.3M | 21.4M | 40.8M | 22.6M |
| Other Income / Gains | 1.5M | -15.7M | 2.3M | 4.5M | 4.4M | 5.0M | 4.1M | 3.7M |
| Net Income | -2.3M | -4.1M | -45.1M | 22.5M | -11.8M | 15.3M | 38.5M | 19.9M |
| EPS (Diluted) | -0.04 | -0.072 | -0.80 | 0.40 | -0.21 | 0.28 | 0.70 | 0.36 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.887 | 0.891 | 0.901 | 0.898 | 0.895 | 0.85 | 0.90 | 0.894 |
| General And Administrative Expenses | 0 | 39.2M | 102.6M | 28.4M | 26.7M | 24.8M | 15.4M | 27.1M |
| Selling And Marketing Expenses | 0 | 83.2M | 77.1M | 65.1M | 63.3M | 54.6M | 54.3M | 58.8M |
| Selling General And Administrative Expenses | 125.2M | 122.4M | 179.7M | 93.6M | 89.9M | 79.4M | 69.8M | 85.9M |
| Other Expenses | 28.0M | 24.5M | 24.3M | 20.8M | 27.4M | 18.6M | 18.5M | 15.8M |
| Cost And Expenses | 215.1M | 197.8M | 252.3M | 153.3M | 160.1M | 152.8M | 134.8M | 145.8M |
| Interest Income | 2.4M | 2.0M | 2.3M | 4.5M | 4.4M | 5.0M | 4.1M | 3.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 26.1M | 25.0M | 24.8M | 21.4M | 20.4M | 18.8M | 20.1M | 20.7M |
| Ebitda | 18.7M | 26.7M | -35.4M | 33.5M | 17.8M | 45.2M | 65.0M | 38.9M |
| Ebitdaratio | 0.09 | 0.126 | -0.184 | 0.202 | 0.119 | 0.26 | 0.37 | 0.231 |
| Operating Income Ratio | -0.036 | 0.065 | -0.314 | 0.073 | -0.068 | 0.123 | 0.232 | 0.134 |
| Income Before Tax | -6.0M | -1.9M | -58.0M | 16.7M | -5.8M | 26.4M | 44.9M | 26.3M |
| Income Before Tax Ratio | -0.029 | -0.009 | -0.302 | 0.101 | -0.039 | 0.151 | 0.256 | 0.156 |
| Income Tax Expense | -3.7M | 2.2M | -12.8M | -5.8M | 6.0M | 11.1M | 6.4M | 6.4M |
| Net Income Ratio | -0.011 | -0.019 | -0.235 | 0.136 | -0.079 | 0.088 | 0.219 | 0.118 |
| Epsdiluted | -0.04 | -0.072 | -0.80 | 0.40 | -0.21 | 0.27 | 0.69 | 0.36 |
| Weighted Average Shs Out | 57.6M | 57.3M | 56.4M | 56.0M | 55.9M | 55.5M | 55.1M | 55.0M |
| Weighted Average Shs Out Dil | 57.6M | 57.3M | 56.6M | 56.6M | 55.9M | 56.5M | 56.0M | 55.7M |